Lipodermatosclerosis secondary to pemetrexed use.
Publication
, Journal Article
Shuster, M; Morley, K; Logan, J; Sequist, LV; Shaw, A; Fidias, P; Kroshinsky, D
Published in: J Thorac Oncol
March 2015
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Thorac Oncol
DOI
EISSN
1556-1380
Publication Date
March 2015
Volume
10
Issue
3
Start / End Page
e11 / e12
Location
United States
Related Subject Headings
- Scleroderma, Localized
- Prognosis
- Pemetrexed
- Oncology & Carcinogenesis
- Middle Aged
- Male
- Lung Neoplasms
- Humans
- Female
- Dermatitis
Citation
APA
Chicago
ICMJE
MLA
NLM
Shuster, M., Morley, K., Logan, J., Sequist, L. V., Shaw, A., Fidias, P., & Kroshinsky, D. (2015). Lipodermatosclerosis secondary to pemetrexed use. J Thorac Oncol, 10(3), e11–e12. https://doi.org/10.1097/JTO.0000000000000426
Shuster, Marina, Keith Morley, Jennifer Logan, Lecia V. Sequist, Alice Shaw, Panos Fidias, and Daniela Kroshinsky. “Lipodermatosclerosis secondary to pemetrexed use.” J Thorac Oncol 10, no. 3 (March 2015): e11–12. https://doi.org/10.1097/JTO.0000000000000426.
Shuster M, Morley K, Logan J, Sequist LV, Shaw A, Fidias P, et al. Lipodermatosclerosis secondary to pemetrexed use. J Thorac Oncol. 2015 Mar;10(3):e11–2.
Shuster, Marina, et al. “Lipodermatosclerosis secondary to pemetrexed use.” J Thorac Oncol, vol. 10, no. 3, Mar. 2015, pp. e11–12. Pubmed, doi:10.1097/JTO.0000000000000426.
Shuster M, Morley K, Logan J, Sequist LV, Shaw A, Fidias P, Kroshinsky D. Lipodermatosclerosis secondary to pemetrexed use. J Thorac Oncol. 2015 Mar;10(3):e11–e12.
Published In
J Thorac Oncol
DOI
EISSN
1556-1380
Publication Date
March 2015
Volume
10
Issue
3
Start / End Page
e11 / e12
Location
United States
Related Subject Headings
- Scleroderma, Localized
- Prognosis
- Pemetrexed
- Oncology & Carcinogenesis
- Middle Aged
- Male
- Lung Neoplasms
- Humans
- Female
- Dermatitis